# Krystal Biotech, Inc.: Form 8-K, filed Feb 26, 2024

- Company: [Krystal Biotech, Inc.](/companies/krys.md) (CIK 1711279)
- Form: 8-K
- Filed: 2024-02-26
- Accepted by EDGAR: Feb 26, 2024, 08:04 ET
- Period: 2024-02-26
- Accession: 0001711279-24-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711279/000171127924000009/krys-20240226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711279/000171127924000009/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711279/000171127924000009/krys-20240226.htm

Filed Feb 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001711279-24-000009. Last ingested by Listed: Nov 2, 2026, 07:08 ET. No prices; not investment advice.